How Much Did Neogen Raise?
Funding & Key Investors

Neogen has secured $1B in total funding, with a recent strategic investment of $1B. This significant capital infusion underscores the company's established position in the food and animal safety sector, signaling a phase of strategic expansion and continued market leadership.

What is Neogen?

Neogen
ManufacturingPharmaceuticalsHealth & Nutrition Products

Neogen Corporation, a global entity headquartered in Lansing, Michigan, specializes in the development, manufacturing, and marketing of a comprehensive suite of products for food and animal safety. Operating across two primary segments, Food Safety and Animal Safety, Neogen provides critical diagnostic test kits, complementary testing solutions, and a range of veterinary instruments, pharmaceuticals, vaccines, and genomics testing services. Its offerings are designed to detect a wide array of contaminants and ensure safety standards in human food, animal feed, and animal health markets worldwide. The company serves a diverse clientele, including food and feed processors, meat and poultry producers, dairies, laboratories, and pharmaceutical manufacturers.

How much funding has Neogen raised?

Neogen has raised a total of $1B across 1 funding round:

2021

Debt

$1B

Debt (2021): $1B with participation from Goldman Sachs and JPMorgan Chase

Key Investors in Neogen

Goldman Sachs

Goldman Sachs is a premier global financial institution providing investment banking, securities, and investment management services. Their involvement suggests a strong belief in Neogen's financial stability and growth potential.

JPMorgan Chase

JPMorgan Chase is a leading global financial services firm offering a wide array of banking and financial services. Their participation indicates confidence in Neogen's strategic direction and market position.

What's next for Neogen?

With a recent major strategic investment, Neogen is poised to further enhance its product development and market reach. The company's focus on critical safety and health solutions, particularly in the food and animal sectors, positions it for sustained growth. Future initiatives are likely to involve expanding its diagnostic capabilities, integrating advanced genomics services, and potentially exploring new geographic markets or strategic partnerships to bolster its enterprise-level offerings. This strategic financing will enable Neogen to reinforce its commitment to innovation and maintain its competitive edge in a vital global industry.

See full Neogen company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingPet Products
Building MaterialsManufacturingConsumer ServicesFuneral Homes & Funeral Related Services
Building MaterialsManufacturingConstruction ManagementConstruction
Building MaterialsManufacturingIndustrial Machinery & Equipment

Frequently Asked Questions Regarding Neogen Financial Insights

What are the most recent funding rounds that Neogen has completed, and what were the funding rounds?
Neogen has recently completed 1 funding rounds: Debt on Dec 15, 2021.
What is the total amount of funding Neogen has raised to date?
Neogen has raised a total of $1B in funding to date.
How many funding rounds has Neogen completed?
Neogen has completed 1 funding rounds.
How much funding did Neogen raise in its most recent funding round?
Neogen raised $1B in its most recent funding round.
Who are the lead investors in Neogen's latest funding round?
The lead investor in Neogen's latest funding round was Goldman Sachs. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Neogen's history?
The largest funding round in Neogen's history was $1B.
See more information about Neogen